Pharmaceutical companies are investing in therapies that target proteins for degradation, with trials ongoing for cancer, autoimmune diseases and neurological disorders.

中文翻译：

---

用于不可成药的 PROTAC 蛋白降解剂进入 3 期试验


制药公司正在投资针对蛋白质降解的疗法，针对癌症、自身免疫性疾病和神经系统疾病的试验正在进行中。